These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17909810)

  • 1. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.
    Zhang L; Zhang Y; Huang PY; Xu F; Peng PJ; Guan ZZ
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):33-8. PubMed ID: 17909810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
    Lim AM; Corry J; Collins M; Peters L; Hicks RJ; D'Costa I; Coleman A; Chua M; Solomon B; Rischin D
    Oral Oncol; 2013 May; 49(5):468-74. PubMed ID: 23369852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.
    Ngan RK; Yiu HH; Lau WH; Yau S; Cheung FY; Chan TM; Kwok CH; Chiu CY; Au SK; Foo W; Law CK; Tse KC
    Ann Oncol; 2002 Aug; 13(8):1252-8. PubMed ID: 12181249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.
    Zhang Y; Zhao L; Huang P; Wu J; Wang F; Huang Y; Zhang L
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):611-5. PubMed ID: 22903536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series.
    Enokida T; Uozumi S; Fujisawa T; Ueda Y; Okano S; Tahara M
    Int J Clin Oncol; 2017 Dec; 22(6):1009-1014. PubMed ID: 28616753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.
    You B; Le Tourneau C; Chen EX; Wang L; Jarvi A; Bharadwaj RR; Kamel-Reid S; Perez-Ordonez B; Mann V; Siu LL
    Am J Clin Oncol; 2012 Jun; 35(3):255-60. PubMed ID: 21358293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
    Chen C; Wang FH; Wang ZQ; An X; Luo HY; Zhang L; Chen YC; Xu RH; Li YH
    Oral Oncol; 2012 Nov; 48(11):1146-51. PubMed ID: 22748450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients.
    Lund B; Hansen OP; Neijt JP; Theilade K; Hansen M
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():61-2. PubMed ID: 8718427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.
    Ma BB; Tannock IF; Pond GR; Edmonds MR; Siu LL
    Cancer; 2002 Dec; 95(12):2516-23. PubMed ID: 12467065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
    Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
    Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
    Hoang T; Kim K; Jaslowski A; Koch P; Beatty P; McGovern J; Quisumbing M; Shapiro G; Witte R; Schiller JH
    Lung Cancer; 2003 Oct; 42(1):97-102. PubMed ID: 14512193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
    Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L
    Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.
    Wang CC; Chang JY; Liu TW; Lin CY; Yu YC; Hong RL
    Head Neck; 2006 Jan; 28(1):74-80. PubMed ID: 16331692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
    Hu S; He X; Dong M; Jia B; Zhou S; Yang J; Yang S; Zhang C; Liu P; Qin Y; Gui L
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):632-6. PubMed ID: 26714607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
    Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
    Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
    Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.
    Wang X; Ni Q; Jin M; Li Z; Wu Y; Zhao Y; Feng F
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):404-7. PubMed ID: 12408777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.
    Offidani M; Mele A; Corvatta L; Marconi M; Malerba L; Olivieri A; Rupoli S; Alesiani F; Leoni P
    Leuk Lymphoma; 2002 Jun; 43(6):1273-9. PubMed ID: 12152996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.